NCT06865040

Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in Patients at High Risk of Postoperative Pulmonary Complications

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 266 (estimated)
• Sponsor: Centre Hospitalier Universitaire, Amiens · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to evaluate, in a clinical trial, the efficacy of peri operative administration of long-acting inhaled ß-2 mimetics on the occurrence of postoperative pulmonary complications

Conditions

• Thoracic Surgery
• Postoperative Pulmonary Complications (PPCs)

Interventions

Type	Name	Description
DRUG	Formoterol Fumarate 12 mcg (Foradil Aerolizer)	Administration in the interventional arm of long-acting inhaled ß-2 mimetics: FORMOTEROL FUMARATE 12 µg pwd inhalation capsule (FORMOTEROL VIATRIS®), taken twice a day intraoperatively from Day-2 to Day 7.
OTHER	Usual treatment	usual treatment

Timeline

• Start date: 2025-07-31
• Primary completion: 2028-03-01
• Completion: 2028-09-01
• First posted: 2025-03-07
• Last updated: 2026-01-16

Locations

1 site across 1 country: France